NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of SOL tokens (“SOL securities”) between March 24, 2020 and the present, inclusive (the “Class Period”), of the important September 6, 202 lead plaintiff deadline in the securities class action lawsuit against Solana Labs, Inc., the […]

NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Missfresh Limited (NASDAQ: MF) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with Missfresh’s June 2021 initial public offering (“IPO” or the “Offering”) of […]

NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Molecular Partners AG (NASDAQ: MOLN): (i) pursuant and/or traceable to the offering documents issued in connection with the Company’s initial public offering conducted on or about June 16, 2021 (the “IPO”); […]

NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of IonQ, Inc. (NYSE: IONQ) between March 30, 2021 and May 2, 2022, both dates inclusive (the “Class Period”), of the important August 1, 2022 lead plaintiff deadline. SO WHAT: If you […]

NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Inotiv, Inc. (NASDAQ: NOTV) between September 21, 2021 and June 13, 2022, both dates inclusive (the “Class Period”), of the important August 22, 2022 lead plaintiff deadline in the securities class […]

Nyxoah to Present at the Canaccord Genuity 42nd Annual Growth Conference Mont-Saint-Guibert, Belgium – July 27, 2022, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will […]